WHO ICTRP trial
Study of the faecal microbiota transfer in capsule form vs. placebo for the…
CTIS2022-500185-94-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2022-500185-94-01 |
|---|---|
| Public title | Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis |
| Scientific title | Randomized, double-blind and multicentric study to assess the efficiency, security and tolerability of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis (EMOTION) - NASH-001 |
| Primary sponsor | Mikrobiomik Healthcare Company S.L. |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Spain |
| Conditions | non-alcoholic steatohepatitis MedDRA version: 22.0Level: PTClassification code: 10053219Term: Non-alcoholic steatohepatitis Class: 100000004871;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] |
| Interventions | Product Name: microcrystalline cellulose Ph Eur, in hypromellose capsules, Product Code:N/A, Pharmaceutical Form: N/A, Other descriptive name: N/A , Strength: , Pharmaceutical form of the placebo: N/A , Product Name: Lyophilized capsules of… |
| Registration date | Nov 28, 2024 |
| Target size | 1 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: